ALK Mutation Status in EGFR-negative Non-small-cell Lung Cancer Patients in Bulgaria

Background: Patients with non-small-cell lung cancer (NSCLC) with anaplastic lymphoma kinase (ALK) rearrangement mutation are found to be 3–13%.

Bibliographic Details
Main Authors:	Djambazov Slaveyko N., Vekov Toni Y., Mekov Evgeni V., Slavchev Georgi S., Petkov Rosen E., Kostadinov Dimitar T., Konteva Ljubliana T.
Format:	Article
Language:	English
Published:	Pensoft Publishers 2018-09-01
Series:	Folia Medica
Subjects:	ALK mutation prevalence non-small-cell lung cancer Bulgaria NSCLC
Online Access:	http://www.degruyter.com/view/j/folmed.2018.60.issue-3/folmed-2018-0010/folmed-2018-0010.xml?format=INT

Internet